6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists

Details for Australian Patent Application No. 2006287160 (hide)

Owner Eli Lilly and Company

Inventors Martinez-Grau, Maria Angeles; Hoying, Richard Charles; Briner, Karin; Camp, Anne Marie; Sapmaz, Selma; Allen, John Gordon; Cases-Thomas, Manuel Javier; Rathmell, Richard Edmund; Williams, Andrew Caerwyn; Mazanetz, Michael Philip; Rothhaar, Roger Ryan; Pokrovskaia, Natalia

Agent Spruson & Ferguson

Pub. Number AU-B-2006287160

PCT Pub. Number WO2007/028131

Priority 60/713,584 01.09.05 US

Filing date 1 September 2006

Wipo publication date 8 March 2007

Acceptance publication date 5 April 2012

International Classifications

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/028131 Priority application(s): WO2007/028131

5 April 2012 Application Accepted

  Published as AU-B-2006287160

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006287169-Implantable devices and methods for treating micro-architecture deterioration of bone tissue

2006287157-Hydroxy substituted 1H-imidazopyridines and methods